Pregnancy and Infant Outcomes in Females Receiving Ocrelizumab for the Treatment of Multiple Sclerosis: Analysis of over 3,000 Pregnancies to Date (S7.004).

Riley Bove, Carlo Pietrasanta, Celia Oreja-Guevara, Kerstin Hellwig, Ruth Dobson, Sandra Vukusic, Chien-Ju Lin, Daniela Goncalves Pereira Alvarez, Dusanka Zecevic, Germano Ferreira, Licinio Craveiro, Noemi Pasquarelli, Thomas McElrath. Pregnancy and Infant Outcomes in Females Receiving Ocrelizumab for the Treatment of Multiple Sclerosis: Analysis of over 3,000 Pregnancies to Date (S7.004). Neurology. 2024 Apr 9; 102(17_supplement_1).